Literature DB >> 24850773

The good, the bad, and the ugly of interleukin-6 signaling.

José J Fuster1, Kenneth Walsh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24850773      PMCID： PMC4194086          DOI： 10.15252/embj.201488856

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  16 in total

1.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

2.  Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice.

Authors:  R Elhage; S Clamens; S Besnard; Z Mallat; A Tedgui; J Arnal; A Maret; F Bayard
Journal:  Atherosclerosis       Date:  2001-06       Impact factor: 5.162

3.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

Authors:  Rachel M McLoughlin; Brendan J Jenkins; Dianne Grail; Anwen S Williams; Ceri A Fielding; Clare R Parker; Matthias Ernst; Nicholas Topley; Simon A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

4.  Interleukin-6 induces cellular insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Robert A Mooney
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Interleukin-6 exacerbates early atherosclerosis in mice.

Authors:  S A Huber; P Sakkinen; D Conze; N Hardin; R Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

6.  Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.

Authors:  Andrew L Carey; Gregory R Steinberg; S Lance Macaulay; Walter G Thomas; Anna G Holmes; Georg Ramm; Oja Prelovsek; Cordula Hohnen-Behrens; Matthew J Watt; David E James; Bruce E Kemp; Bente K Pedersen; Mark A Febbraio
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

7.  Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.

Authors:  Bernhard Schieffer; Tina Selle; Andres Hilfiker; Denise Hilfiker-Kleiner; Karsten Grote; Uwe J F Tietge; Christian Trautwein; Maren Luchtefeld; Christian Schmittkamp; Sylvia Heeneman; Mat J A P Daemen; Helmut Drexler
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

8.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Authors:  Hideo Yasukawa; Masanobu Ohishi; Hiroyuki Mori; Masaaki Murakami; Takatoshi Chinen; Daisuke Aki; Toshikatsu Hanada; Kiyoshi Takeda; Shizuo Akira; Masahiko Hoshijima; Toshio Hirano; Kenneth R Chien; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

9.  Impaired immune and acute-phase responses in interleukin-6-deficient mice.

Authors:  M Kopf; H Baumann; G Freer; M Freudenberg; M Lamers; T Kishimoto; R Zinkernagel; H Bluethmann; G Köhler
Journal:  Nature       Date:  1994-03-24       Impact factor: 49.962

10.  Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.

Authors:  Jan Mauer; Bhagirath Chaurasia; Julia Goldau; Merly C Vogt; Johan Ruud; Khoa D Nguyen; Sebastian Theurich; A Christine Hausen; Joel Schmitz; Hella S Brönneke; Emma Estevez; Tamara L Allen; Andrea Mesaros; Linda Partridge; Mark A Febbraio; Ajay Chawla; F Thomas Wunderlich; Jens C Brüning
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606
View more
  44 in total

1.  IL-6 Trans-Signaling Drives Murine Crescentic GN.

Authors:  Gerald S Braun; Yoshikuni Nagayama; Yuichi Maruta; Felix Heymann; Claudia R van Roeyen; Barbara M Klinkhammer; Peter Boor; Luigi Villa; David J Salant; Ute Raffetseder; Stefan Rose-John; Tammo Ostendorf; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2015-06-03       Impact factor: 10.121

2.  Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.

Authors:  Marta Helena Kubala; Vasu Punj; Veronica Rae Placencio-Hickok; Hua Fang; G Esteban Fernandez; Richard Sposto; Yves Albert DeClerck
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

Review 3.  CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.

Authors:  Shannon L Maude; David T Teachey; David L Porter; Stephan A Grupp
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

4.  The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism.

Authors:  Christian von Loeffelholz; Stefanie Lieske; Frank Neuschäfer-Rube; Diana M Willmes; Nathanael Raschzok; Igor M Sauer; Jörg König; Martin F Fromm; Paul Horn; Antonios Chatzigeorgiou; Andrea Pathe-Neuschäfer-Rube; Jens Jordan; Andreas F H Pfeiffer; Geltrude Mingrone; Stefan R Bornstein; Peter Stroehle; Christoph Harms; F Thomas Wunderlich; Stephen L Helfand; Michel Bernier; Rafael de Cabo; Gerald I Shulman; Triantafyllos Chavakis; Gerhard P Püschel; Andreas L Birkenfeld
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

5.  Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1.

Authors:  Michelle A Sugimoto; Ana Luíza C Ribeiro; Bruno R C Costa; Juliana P Vago; Kátia M Lima; Fernanda S Carneiro; Mylena Maira O Ortiz; Graziele Letícia N Lima; Aline A F Carmo; Renata M Rocha; Denise A Perez; Alessandra C Reis; Vanessa Pinho; Lindsey A Miles; Cristiana C Garcia; Mauro M Teixeira; Lirlândia P Sousa
Journal:  Blood       Date:  2017-03-20       Impact factor: 22.113

Review 6.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

Review 7.  The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release.

Authors:  Stephan Wueest; Daniel Konrad
Journal:  Adipocyte       Date:  2018-08-03       Impact factor: 4.534

8.  Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.

Authors:  Annayya R Aroor; Guanghong Jia; Javad Habibi; Zhe Sun; Francisco I Ramirez-Perez; Barron Brady; Dongqing Chen; Luis A Martinez-Lemus; Camila Manrique; Ravi Nistala; Adam T Whaley-Connell; Vincent G Demarco; Gerald A Meininger; James R Sowers
Journal:  Metabolism       Date:  2017-06-21       Impact factor: 8.694

9.  The prospective association between stressful life events and inflammation among adolescents with a history of early institutional rearing.

Authors:  Alva Tang; Mark Wade; Nathan A Fox; Charles A Nelson; Charles H Zeanah; Natalie Slopen
Journal:  Dev Psychopathol       Date:  2020-12

10.  Circulating inflammatory biomarkers in adolescents: evidence of interactions between chronic pain and obesity.

Authors:  Keri R Hainsworth; Pippa M Simpson; Hershel Raff; Mitchell H Grayson; Liyun Zhang; Steven J Weisman
Journal:  Pain Rep       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.